series-c-plus
Stage
2
Investors
About
Perceive Bio develops novel therapeutics focused on protecting vision by targeting retinal degeneration and neuroprotection, leveraging decades of academic research in protective biology.
Explore Perceive Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.